RELAPSED LEUKEMIA
Clinical trials for RELAPSED LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radical Two-Part cell transplant trial offers hope for leukemia patients out of options
Disease control Recruiting nowThis early-phase study is testing a new two-step approach for patients with leukemia that has come back or not responded to standard treatments. First, patients receive chemotherapy and an infusion of immune cells from a partially matched donor to try to reduce the cancer. Then, …
Matched conditions: RELAPSED LEUKEMIA
Phase: PHASE1 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for Tough-to-Treat blood cancer: trial tests Triple-Drug attack
Disease control Recruiting nowThis study is testing whether adding a new oral drug, roginolisib, to two standard drugs (venetoclax and rituximab) is safe and works better for people with chronic lymphocytic leukemia (CLL) that has come back or stopped responding to treatment. About 64 participants will receiv…
Matched conditions: RELAPSED LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Jennifer R. Brown, MD, PhD • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC